To better understand the impact of immune dysfunction on survival outcomes of HL and HIV-HL patients, we investigated the prognostic value of CD4+ T-cell counts, CD8+ T-cell counts, and the CD4/CD8 ratio. The gene discussed is CD8A; the disease is Hodgkins lymphoma.